QUESTIONSExL Pharmas Proof of Mechanism Decision Making for Oncology Imaging Biomarker Trials (PPMD)
Venue: Webinar
Location: Webinar, United States
| Event Date/Time: Jun 25, 2009 |
Report as SpamDescription
TOPICS TO BE DISCUSSED:
1. Setting up the study for success: What considerations are critical for ensuring successful image acquisition and analysis?
2. Patient selection, sample size and lesion selection: How do you enhance the chance of making the right POM decision with a severely limited number of patients?
3. Establishing POM criteria: What are the options and how do you choose the best one?
4. Blinded and Independent reads in a severely limited study: Should we be even more careful to avoid confounding or biased results?
1. Setting up the study for success: What considerations are critical for ensuring successful image acquisition and analysis?
2. Patient selection, sample size and lesion selection: How do you enhance the chance of making the right POM decision with a severely limited number of patients?
3. Establishing POM criteria: What are the options and how do you choose the best one?
4. Blinded and Independent reads in a severely limited study: Should we be even more careful to avoid confounding or biased results?
Venue
Additional Information
Who should Attend
* Clinical Diagnostics
* Medical Imaging
* Oncology Imaging
* Biomedical Imaging
* Drug Discovery and Development
* Biomarker Technology
* Clinical Technology
* Clinical Pharmacology
* Clinical Research
* Clinical Strategy
